Pathophysiology of food-induced anaphylaxis

Current Allergy and Asthma Reports

Volumn 8, Issue 3, 2008, Pages 201-208

  Lemon Mulé, Heather ^b   Nowak Wegrzyn, Anna ^b   Berin, Cecilia ^b   Knight, Adina K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADRENALIN; ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CARBOXYPEPTIDASE A; CD23 ANTIGEN; CHONDROITIN SULFATE; CHYMASE; CORTICOSTEROID; FC RECEPTOR; FOOD ALLERGEN; HEPARIN; HERBACEOUS AGENT; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PROSTAGLANDIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; THROMBOCYTE ACTIVATING FACTOR; TRYPTASE; UNINDEXED DRUG; ANTIGEN;

ALLERGENICITY; ANAPHYLAXIS; CYTOKINE RELEASE; DESENSITIZATION; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; ENZYME BLOOD LEVEL; EXERCISE; FATALITY; FOOD ALLERGY; FOOD PROCESSING; HIGH RISK POPULATION; HUMAN; IMMUNOPATHOGENESIS; MAST CELL DEGRANULATION; MAXIMUM PLASMA CONCENTRATION; MILK ALLERGY; NONHUMAN; PATHOPHYSIOLOGY; PEANUT ALLERGY; PRICK TEST; PRIMARY PREVENTION; PROTEIN TRANSPORT; PROVOCATION TEST; REVIEW; RISK FACTOR; STOMACH PH; ANIMAL; BASOPHIL; DISEASE MODEL; IMMUNOLOGY; MAST CELL; METABOLISM; PHYSIOLOGY;

ANAPHYLAXIS; ANIMALS; ANTIGENS; BASOPHILS; DISEASE MODELS, ANIMAL; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; MAST CELLS;

EID: 47749130040     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-008-0034-6     Document Type: Review

References (50)

1. Sicherer SH, Sampson HA: Food allergy. J Allergy Clin Immunol 2006, 117:S470-S475.
2. Bock SA, Munoz-Furlong BA, Sampson HA: Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001, 107:191-193.
3. Wang J, Sampson HA: Food anaphylaxis. Clin Exp Allergy 2007, 37:651-660.
4. Keet CA, Wood RA: Food allergy and anaphylaxis. Immunol Allergy Clin North Am 2007, 27:193-212.
5. Simons FER, Chad ZH, Gold M: Real-time reporting of anaphylaxis in infants, children and adolescents by physicians involved in the Canadian Pediatric Surveillance Program [abstract]. J Allergy Clin Immunol 2002, 109:S181.
6. Sampson HA, Munoz-Furlong A, Campbell RL, et al.: Second symposium on the definition of and management of anaphylaxis: summary report: Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006, 117:391-397.
7. Simons FER, Frew AJ, Ansotegui IJ, et al.: Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 2007, 120(Suppl):S2-S24.
8. Li XM, Schofield JD, Huang CK, et al.: A murine model of IgE-mediated cow's milk hypersensitivity. J Allergy Clin Immunol 1999, 103:206-214.
9. Li XM, Serebrisky D, Lee SY, et al.: A murine model of peanut anaphylaxis: T-and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol 2000, 106:150-158.
10. Sun J, Arias K, Alvarez D, et al.: Impact of CD40 ligand, B cells and mast cells in peanut-induced anaphylactic responses. J Immunol 2007, 179:6696-6703.
11. Leung DY, Sampson HA, Yunginger JW, et al.: Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003, 348:986-993.
12. Finkelman FD: Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 2007, 120:506-515.
13. Berin MC, Kiliaan AJ, Yang PC, et al.: Rapid transepithelial transport in rat jejunum: impact of sensitization and the hypersensitivity reaction. Gastroenterology 1997, 113:856-864.
14. Berin MC, Kiliaan AJ, Yang PC, et al.: The influence of mast cells on pathways on transepithelial antigen transport in rat intestine. J Immunol 1998, 161:2561-2566.
15. Yang PC, Berin MC, Yu LC, et al.: Enhanced intestinal transepithelial antigen transport in allergic rats is mediated by IgE and CD23 (Fc epsilon RII). J Clin Invest 2000, 106:879-876.
16. Li H, Nowak-Wegrzyn A, Charlop-Powers, Z, et al.: Transcytosis of IgE-antigen complexes by CD23a in human intestinal epithelial cells and its role in food allergy. Gastroenterology 2006, 131:47-58.
17. Yano H, Kato Y, Matsuda T: Acute exercise induces gastrointestinal leakage of allergen in lysozyme-sensitized mice. Eur J Appl Physiol 2002, 87:358-364.
18. Matsuo H, Morimoto K, Akaki T, et al.: Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise induced anaphylaxis. Clin Exp Allergy 2005, 35:461-466.
19. Palosuo K, Varjonen E, Nurkkala J, et al.: Transglutaminase-mediated cross-linking of a peptic fraction of ω-5 gliadin enhances IgE reactivity in wheat-dependent, exercise-induced anaphylaxis. J Allergy Clin Immunol 2003, 111:1386-1392.
20. Untersmayr E, Bakos N, Scholl I, et al.: Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients. FASEB J 2005, 19:656-658.
21. Untersmayr E, Vestergaard H, Malling HJ, et al.: Incomplete digestion of codfish represents a risk factor for anaphylaxis in patients with allergy. J Allergy Clin Immunol 2007, 119:711-717.
22. Beyer K, Morrow E, Li XM, et al.: Effects of cooking methods on peanut allergenicity. J Allergy Clin Immunol 2001, 107:1077-1081.
23. Ogawa Y, Grant JA: Mediators of anaphylaxis. Immunol Allergy Clin North Am 2007, 27:249-260.
24. Pejler G, Abrink M, Wernersson M: Mast cell proteases. Adv Immunol 2007, 95:167-255.
25. Kaliner M, Sigler R, Summers R, Shelhamer JH: Effects of infused histamine: analysis of the effects of H1 and H2 histamine receptor antagonists on cardiovascular and pulmonary responses. J Allergy Clin Immunol 1981, 68:365-371.
26. Heflin CR, Brewer KL, Hack JB, Meggs WJ: Heparin reverses anaphylactoid shock in a porcine model. Ann Emerg Med 2006, 48:190-193.
27. Cuss FM, Dixon CM, Barnes PJ: Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1996, 2:189-192.
28. Rodriguez-Roisin R, Félez MA, Chung KF, et al.: Platelet-activating factor causes ventilation-perfusion mismatch in humans. J Clin Invest 1994, 93:188-194.
29. Vadas P, Gold M, Perelman B, et al.: Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008, 358:28-35.
30. Lieberman P: Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 2005, 95:217-226.
31. Perskvist N, Edston E: Differential accumulation of pulmonary and mast cell-subsets and eosinophils between fatal anaphylaxis and asthma death: a post-mortem comparative study. Forensic Sci Int 2007, 169:43-49.
32. Yang PC, Berin MC, Yu L, Perdue MH: Mucosal pathophysiology and inflammatory changes in the late phase of the intestinal allergic reaction in the rat. Am J Pathol 2001, 158:681-690.
33. Sampson HA, Mendelson L, Rosen JP: Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992, 327:380-384.
34. Sampson HA, Jolie PL: Increased plasma histamine concentrations after food challenges in children with atopic dermatitis. N Engl J Med 1984, 311:372-376.
35. Caughey GH: Tryptase genetics and anaphylaxis. J Allergy Clin Immunol 2006, 117:1411-1414.
36. Schwartz LB, Irani A-MA, Roller K, et al.: Quantitation of histamine, tryptase and chymase in dispersed human T and TC mast cells. J Immunol 1987, 138:2611-2615.
37. Scudamore CL, Thornton EM, McMillan L, et al.: Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J Exp Med 1995, 182:1871-1881.
38. Kaliner M, Dyer J, Merlin S, et al.: Increased urine histamine and contrast media reaction. Invest Radiol 1984, 19:116-118.
39. Zhou X, Buckley MG, Lau LC, et al.: Mast cell carboxypeptidase as a new clinical marker for anaphylaxis [abstract]. J Allergy Clin Immunol 2006, 117:S85.
40. Pereria B, Venter C, Grundy J, et al.: Prevalence of sensitization to food allergens, reported adverse reactions to foods, food avoidance, and food hypersensitivity among teenagers. J Allergy Clin Immunol 2005, 116:884-892.
41. Bock SA: Prospective appraisal of complaints of adverse reactions to foods in children in the first 3 years of life. Pediatrics 1987, 79:683-688.
42. Shreffler WG, Beyer K, Tearina Chu TH, et al.: Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol 2004, 113:776-782.
43. Jarvinen K, Beyer K, Vila L, et al.: Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy. Allergy 2007, 62:758-765.
44. Gebhardt T, Gerhard R, Bedoui S, et al.: β2-Adrenoceptor-mediated suppression of human intestinal mast cell functions is caused by disruption of filamentous actin dynamics. Eur J Immunol 2005, 35:1124-1132.
45. Lieberman P: Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol 2003, 3:313-318.
46. Simons FE: First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 2004, 113:837-844.
47. Douglas DM, Sukenick E, Andrade WP, Brown JS: Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol 1994, 93:977-985.
48. Stark BJ, Sullivan TJ: Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986, 78:76-83.
49. Srivastava KD, Kattan JD, Zou ZM, et al.: The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of anaphylaxis. J Allergy Clin Immunol 2005, 115:171-178.
50. Sicherer SH, Samspon HA: Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol 2007, 120:491-503.